ZJYL
Income statement / Annual
Last year (2024), Jin Medical International Ltd.'s total revenue was $23.50 M,
an increase of 18.57% from the previous year.
In 2024, Jin Medical International Ltd.'s net income was $3.68 M.
See Jin Medical International Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
| Operating Revenue |
$23.50 M |
$19.82 M |
$19.19 M |
$20.76 M |
$16.19 M |
$20.37 M |
$20.91 M |
| Cost of Revenue |
$14.00 M
|
$13.04 M
|
$12.99 M
|
$14.40 M
|
$10.70 M
|
$12.86 M
|
$13.25 M
|
| Gross Profit |
$9.50 M
|
$6.78 M
|
$6.20 M
|
$6.36 M
|
$5.50 M
|
$7.51 M
|
$7.66 M
|
| Gross Profit Ratio |
0.4
|
0.34
|
0.32
|
0.31
|
0.34
|
0.37
|
0.37
|
| Research and Development Expenses |
$1.50 M
|
$1.54 M
|
$1.89 M
|
$1.57 M
|
$1.26 M
|
$1.13 M
|
$1.20 M
|
| General & Administrative Expenses |
$3.26 M
|
$1.92 M
|
$1.77 M
|
$1.67 M
|
$1.50 M
|
$1.60 M
|
$1.72 M
|
| Selling & Marketing Expenses |
$1.10 M
|
$453,311.00
|
$402,013.00
|
$488,998.00
|
$385,090.00
|
$381,113.00
|
$513,098.00
|
| Selling, General & Administrative Expenses |
$4.37 M
|
$2.37 M
|
$2.18 M
|
$2.16 M
|
$1.88 M
|
$1.98 M
|
$2.23 M
|
| Other Expenses |
$0.00
|
$0.00
|
$244,115.00
|
$194,982.00
|
$123,275.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.86 M
|
$3.92 M
|
$4.07 M
|
$3.73 M
|
$3.14 M
|
$3.11 M
|
$3.33 M
|
| Cost And Expenses |
$19.86 M
|
$16.95 M
|
$17.06 M
|
$18.13 M
|
$13.84 M
|
$15.96 M
|
$16.59 M
|
| Interest Income |
$466,524.00
|
$182,682.00
|
$181,605.00
|
$0.00
|
$0.00
|
$0.00
|
$25,244.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$9,492.00
|
$112,404.00
|
$22,846.00
|
$0.00
|
| Depreciation & Amortization |
$346,132.00
|
$225,902.00
|
$357,269.00
|
$341,245.00
|
$324,925.00
|
$344,036.00
|
$368,263.00
|
| EBITDA |
$3.98 M |
$3.09 M |
$3.10 M |
$3.23 M |
$2.79 M |
$4.49 M |
$4.60 M |
| EBITDA Ratio |
0.17
|
0.16
|
0.12
|
0.15
|
0.17
|
0.23
|
0.22
|
| Operating Income Ratio |
0.15
|
0.14
|
0.11
|
0.13
|
0.15
|
0.22
|
0.2
|
| Total Other Income/Expenses Net |
$544,966.00
|
$354,675.00
|
$612,114.00
|
$248,845.00
|
-$1,521.00
|
-$276,611.00
|
$71,024.00
|
| Income Before Tax |
$4.18 M
|
$3.22 M
|
$2.74 M
|
$2.88 M
|
$2.35 M
|
$4.13 M
|
$4.30 M
|
| Income Before Tax Ratio |
0.18
|
0.16
|
0.14
|
0.14
|
0.15
|
0.2
|
0.21
|
| Income Tax Expense |
$763,879.00
|
$343,707.00
|
$36,111.00
|
$248,641.00
|
$147,154.00
|
$479,629.00
|
$616,880.00
|
| Net Income |
$3.68 M
|
$2.88 M
|
$2.71 M
|
$2.63 M
|
$2.21 M
|
$3.65 M
|
$3.68 M
|
| Net Income Ratio |
0.16
|
0.15
|
0.14
|
0.13
|
0.14
|
0.18
|
0.18
|
| EPS |
0.0235 |
0.0198 |
0.34 |
0.33 |
0.28 |
0.46 |
0.0092 |
| EPS Diluted |
0.0235 |
0.0198 |
0.34 |
0.33 |
0.28 |
0.46 |
0.0092 |
| Weighted Average Shares Out |
$156.42 M
|
$145.14 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$400.01 M
|
| Weighted Average Shares Out Diluted |
$156.40 M
|
$145.14 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$400.00 M
|
| Link |
|
|
|
|
|
|
|
